Inovio公开发行1750万美元的股票和期权

2026-04-02 21:03

INOVIO Pharmaceuticals (Nasdaq: INO) on Thursday said it has priced an underwritten public offering expected to raise about $17.5 million in gross proceeds.
The offering consists of 12.5 million shares of common stock along with Series A and Series B warrants to purchase up to 12.5 million shares each, all priced at a combined $1.40 per share and accompanying warrants.
The warrants will have an exercise price of $1.40 per share.
The company also granted the underwriter a 30-day option to purchase up to an additional 1.875 million shares and associated warrants.
The offering is expected to close around April 6, subject to customary conditions.
INO -25.28% premarket to $1.3.
Source: Press Release

More on Inovio Pharmaceuticals